Arachidonic Acid Activates K-Cl-cotransport in HepG2 Human Hepatoblastoma Cells.

The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology
Yong Soo Lee

Abstract

K(+)-Cl(-)-cotransport (KCC) has been reported to have various cellular functions, including proliferation and apoptosis of human cancer cells. However, the signal transduction pathways that control the activity of KCC are currently not well understood. In this study we investigated the possible role of phospholipase A(2) (PLA(2))-arachidonic acid (AA) signal in the regulatory mechanism of KCC activity. Exogenous application of AA significantly induced K(+) efflux in a dose-dependent manner, which was completely blocked by R-(+)-[2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl]oxy]acetic acid (DIOA), a specific KCC inhibitor. N-Ethylmaleimide (NEM), a KCC activator-induced K(+) efflux was significantly suppressed by bromoenol lactone (BEL), an inhibitor of the calcium-independent PLA(2) (iPLA(2)), whereas it was not significantly altered by arachidonyl trifluoromethylketone (AACOCF(3)) and p-bromophenacyl bromide (BPB), inhibitors of the calcium-dependent cytosolic PLA(2) (cPLA(2)) and the secretory PLA(2) (sPLA(2)), respectively. NEM increased AA liberation in a dose- and time-dependent manner, which was markedly prevented only by BEL. In addition, the NEM-induced ROS generation was significantly reduced b...Continue Reading

References

Nov 1, 1992·The American Journal of Physiology·P K LaufE Delpire
Jan 1, 1991·The American Journal of Physiology·D M Kaji, Y Tsukitani
May 1, 1988·British Journal of Haematology·J Stuart, J C Ellory
Dec 1, 1994·The American Journal of Physiology·H AmlalM Bichara
Oct 1, 1994·The American Journal of Physiology·E Weil-MaslanskyS Sasson
Jan 1, 1993·The American Journal of Physiology·L C Starke, M L Jennings
Feb 1, 1993·The American Journal of Physiology·C H Joiner
May 28, 1996·Proceedings of the National Academy of Sciences of the United States of America·D G TangK V Honn
Jul 1, 1996·The American Journal of Physiology·P W FlatmanP K Lauf
Aug 1, 1996·Pflügers Archiv : European journal of physiology·Y R Weaver, A R Cossins
Mar 13, 1999·Biochemical Pharmacology·G Leoncini, M G Signorello
Sep 16, 1999·Biochemical Pharmacology·G Leoncini, M G Signorello
Feb 9, 2000·American Journal of Physiology. Cell Physiology·N C AdragnaP K Lauf
Sep 26, 2000·American Journal of Physiology. Cell Physiology·M C MuzyambaJ S Gibson
Aug 14, 2003·Biochemical and Biophysical Research Communications·Maren LuchtefeldBernhard Schieffer
Nov 25, 2003·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·John S GibsonClive J Ellory
Mar 31, 2004·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Christina C Leslie
Feb 16, 2005·The Journal of Membrane Biology·N C AdragnaP K Lauf
Apr 10, 2007·Archivum Immunologiae Et Therapiae Experimentalis·Charles S Hii, Antonio Ferrante
Dec 29, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sang-Ho ChoiFrancesca Bosetti
Sep 9, 2008·Trends in Molecular Medicine·Hedi HariziNorbert Gualde

❮ Previous
Next ❯

Citations

Nov 30, 2013·Naunyn-Schmiedeberg's Archives of Pharmacology·A HolowniaJ J Braszko
Aug 9, 2011·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Mattia Di NunzioAlessandra Bordoni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.